The ruling removes a minor litigation overhang. With no financial exposure and a clean win, there is no material read-through for CME's operations or earnings. Monitor for any appeal (unlikely given the strength of the ruling).
Price Chart
Executive Summary
CME Group won summary judgment in a former employee's discrimination and retaliation lawsuit. The court found no evidence that CME's termination decision was based on protected characteristics or retaliatory motive, and dismissed all claims with prejudice. This removes a low-probability litigation overhang with no material financial exposure.
Court Ruling Details
Key Facts
- Former employee Paul Kuscher sued CME Group for discrimination (race, national origin, gender) and retaliation under Title VII and the Illinois Human Rights Act.
- The court granted CME's motion for summary judgment on all counts, finding Kuscher failed to establish a prima facie case of discrimination or a causal link for retaliation.
- The ruling is a final judgment with prejudice, terminating the case entirely.
- No damages were awarded; the case had no disclosed settlement reserve or material financial exposure.
- The underlying allegations had been public since the case was filed in 2022, so the ruling is a confirmation event rather than a surprise.
Financial Impact
No damages awarded; case dismissed with prejudice. Legal costs were likely immaterial relative to CME's $107.7B market cap.
Risk Factors
- Plaintiff could appeal to the Seventh Circuit, though the factual record strongly supports CME and appeal prospects appear low.
- No other known related litigation against CME on similar grounds.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 court opinion from CourtListener.
| Document | Accession Number |
|---|---|
| COURT-RULING Data (Synthetic) | court-o0i6c2ic-CME |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 15, 2026 17d ago | Insider Cluster | $275.09 $267.21 | ▼ −2.86% | ▼ −3.68% | $262.85 (−4.45%) |
Aug 19, 2026 6w ago | ANALYST-DOWNGRADE | — | awaiting T+5 | — | — |
Jul 22, 2026 10w ago | 8-K | $249.24 $265.44 | ▲ +6.50% | ▲ +8.90% | $262.85 (+5.46%) |
Jun 18, 2026 15w ago | ANALYST-UPGRADE | $246.38 $225.00 | ▼ −8.68% | ▼ −7.01% | $262.85 (+6.68%) |
Jun 17, 2026 15w ago | 8-K | $252.54 $231.68 | ▼ −8.26% | ▼ −7.22% | $262.85 (+4.08%) |
Jun 11, 2026 16w ago | ANALYST-UPGRADE | $269.53 $246.38 | ▼ −8.59% | ▼ −9.26% | $262.85 (−2.48%) |
May 19, 2026 19w ago | DEFA14A | $290.04 $277.34 | ▼ −4.38% | ▼ −6.18% | $262.85 (−9.37%) |
May 19, 2026 19w ago | Insider Cluster | $290.04 $277.34 | ▼ −4.38% | ▼ −6.18% | $262.85 (−9.37%) |
Apr 22, 2026 23w ago | 8-K | $285.58 $283.30 | ▲ +0.80% | ▲ +0.85% | $262.85 (+7.96%) |
Mar 27, 2026 27w ago | Court Ruling | $293.69 $308.51 | ▲ +5.05% | ▲ +1.18% | $262.85 (−10.50%) |
US Market Status
Subscribe to SecBot
Get Real-Time Court Ruling Intelligence
Market-moving court rulings analyzed within minutes. Patent verdicts, antitrust decisions, class certifications, and more — parsed and scored by AI.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access